A Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease
Clinical trial NCT00679627 · TERMINATED
Trial details
- NCT number
- NCT00679627
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2012-04-01
- Enrollment
- 2051
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.